Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €69.00 by Jefferies Financial Group

Jefferies Financial Group set a €69.00 ($80.23) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Wednesday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other research firms have also recently weighed in on FME. UBS Group set a €92.00 ($106.98) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Tuesday, July 30th. Credit Suisse Group set a €71.00 ($82.56) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. set a €85.30 ($99.19) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, July 31st. Morgan Stanley set a €58.00 ($67.44) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Thursday, September 12th. Finally, Deutsche Bank set a €100.00 ($116.28) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, July 31st. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of Buy and an average target price of €79.60 ($92.56).

FME stock opened at €63.02 ($73.28) on Wednesday. The company has a quick ratio of 0.63, a current ratio of 0.99 and a debt-to-equity ratio of 105.17. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €55.44 ($64.47) and a twelve month high of €91.74 ($106.67). The stock has a market capitalization of $19.08 billion and a price-to-earnings ratio of 15.63. The firm’s fifty day simple moving average is €61.48 and its two-hundred day simple moving average is €67.75.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: Understanding dividend yield and dividend payout ratio

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.